肝切除术后HCC复发的动态风险分析

IF 15.8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Hepatology Pub Date : 2022-02-18 DOI:10.1002/hep.32411
Tommy Ivanics, Carla Fiorella Murillo Perez, Marco P. A. W. Claasen, Madhukar S. Patel, Gabriela Morgenshtern, Lauren Erdman, Chaya Shwaartz, Luckshi Rajendran, Grainne M. O’Kane, Bettina E. Hansen, Sean P Cleary, Gonzalo Sapisochin
{"title":"肝切除术后HCC复发的动态风险分析","authors":"Tommy Ivanics,&nbsp;Carla Fiorella Murillo Perez,&nbsp;Marco P. A. W. Claasen,&nbsp;Madhukar S. Patel,&nbsp;Gabriela Morgenshtern,&nbsp;Lauren Erdman,&nbsp;Chaya Shwaartz,&nbsp;Luckshi Rajendran,&nbsp;Grainne M. O’Kane,&nbsp;Bettina E. Hansen,&nbsp;Sean P Cleary,&nbsp;Gonzalo Sapisochin","doi":"10.1002/hep.32411","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and Aims</h3>\n \n <p>Following liver resection (LR) for HCC, the likelihood of survival is dynamic, in that multiple recurrences and/or metastases are possible, each having variable impacts on outcomes. We sought to evaluate the natural progression, pattern, and timing of various disease states after LR for HCC using multistate modeling and to create a practical calculator to provide prognostic information for patients and clinicians.</p>\n </section>\n \n <section>\n \n <h3> Approach and Results</h3>\n \n <p>Adult patients undergoing LR for HCC between January 2000 and December 2018 were retrospectively identified at a single center. Multistate analysis modeled post-LR tumor progression by describing transitions between distinct disease states. In this model, the states included surgery, intrahepatic recurrence (first, second, third, fourth, fifth), distant metastasis with or without intrahepatic recurrence, and death. Of the 486 patients included, 169 (34.8%) remained recurrence-free, 205 (42.2%) developed intrahepatic recurrence, 80 (16.5%) developed distant metastasis, and 32 (7%) died. For an average patient having undergone LR, there was a 33.1% chance of remaining disease-free, a 31.0% chance of at least one intrahepatic recurrence, a 16.3% chance of distant metastasis, and a 19.8% chance of death within the first 60 months post-LR. The transition probability from surgery to first intrahepatic recurrence, without a subsequent state transition, increased from 3% (3 months) to 17.4% (30 months) and 17.2% (60 months). Factors that could modify these probabilities included tumor size, satellite lesions, and microvascular invasion. The online multistate model calculator can be found on https://multistatehcc.shinyapps.io/home/.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>In contrast to standard single time-to-event estimates, multistate modeling provides more realistic prognostication of outcomes after LR for HCC by taking into account many postoperative disease states and transitions between them. Our multistate modeling calculator can provide meaningful data to guide the management of patients undergoing postoperative surveillance and therapy.</p>\n </section>\n </div>","PeriodicalId":177,"journal":{"name":"Hepatology","volume":"76 5","pages":"1291-1301"},"PeriodicalIF":15.8000,"publicationDate":"2022-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":"{\"title\":\"Dynamic risk profiling of HCC recurrence after curative intent liver resection\",\"authors\":\"Tommy Ivanics,&nbsp;Carla Fiorella Murillo Perez,&nbsp;Marco P. A. W. Claasen,&nbsp;Madhukar S. Patel,&nbsp;Gabriela Morgenshtern,&nbsp;Lauren Erdman,&nbsp;Chaya Shwaartz,&nbsp;Luckshi Rajendran,&nbsp;Grainne M. O’Kane,&nbsp;Bettina E. Hansen,&nbsp;Sean P Cleary,&nbsp;Gonzalo Sapisochin\",\"doi\":\"10.1002/hep.32411\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background and Aims</h3>\\n \\n <p>Following liver resection (LR) for HCC, the likelihood of survival is dynamic, in that multiple recurrences and/or metastases are possible, each having variable impacts on outcomes. We sought to evaluate the natural progression, pattern, and timing of various disease states after LR for HCC using multistate modeling and to create a practical calculator to provide prognostic information for patients and clinicians.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Approach and Results</h3>\\n \\n <p>Adult patients undergoing LR for HCC between January 2000 and December 2018 were retrospectively identified at a single center. Multistate analysis modeled post-LR tumor progression by describing transitions between distinct disease states. In this model, the states included surgery, intrahepatic recurrence (first, second, third, fourth, fifth), distant metastasis with or without intrahepatic recurrence, and death. Of the 486 patients included, 169 (34.8%) remained recurrence-free, 205 (42.2%) developed intrahepatic recurrence, 80 (16.5%) developed distant metastasis, and 32 (7%) died. For an average patient having undergone LR, there was a 33.1% chance of remaining disease-free, a 31.0% chance of at least one intrahepatic recurrence, a 16.3% chance of distant metastasis, and a 19.8% chance of death within the first 60 months post-LR. The transition probability from surgery to first intrahepatic recurrence, without a subsequent state transition, increased from 3% (3 months) to 17.4% (30 months) and 17.2% (60 months). Factors that could modify these probabilities included tumor size, satellite lesions, and microvascular invasion. The online multistate model calculator can be found on https://multistatehcc.shinyapps.io/home/.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>In contrast to standard single time-to-event estimates, multistate modeling provides more realistic prognostication of outcomes after LR for HCC by taking into account many postoperative disease states and transitions between them. Our multistate modeling calculator can provide meaningful data to guide the management of patients undergoing postoperative surveillance and therapy.</p>\\n </section>\\n </div>\",\"PeriodicalId\":177,\"journal\":{\"name\":\"Hepatology\",\"volume\":\"76 5\",\"pages\":\"1291-1301\"},\"PeriodicalIF\":15.8000,\"publicationDate\":\"2022-02-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/hep.32411\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hep.32411","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 10

摘要

背景和目的肝癌肝切除术(LR)后,生存的可能性是动态的,因为多发性复发和/或转移是可能的,每一个都对结果有不同的影响。我们试图使用多状态模型来评估肝癌LR后各种疾病状态的自然进展、模式和时间,并创建一个实用的计算器,为患者和临床医生提供预后信息。方法和结果在2000年1月至2018年12月期间,在单个中心回顾性地确定了接受肝细胞癌LR治疗的成年患者。多状态分析通过描述不同疾病状态之间的转变来模拟lr后肿瘤进展。在这个模型中,状态包括手术、肝内复发(第一、第二、第三、第四、第五)、伴有或不伴有肝内复发的远处转移和死亡。在纳入的486例患者中,169例(34.8%)无复发,205例(42.2%)发生肝内复发,80例(16.5%)发生远处转移,32例(7%)死亡。对于接受过肝移植的患者,在肝移植后的前60个月内,平均有33.1%的机会没有疾病,31.0%的机会至少有一次肝内复发,16.3%的机会远处转移,19.8%的机会死亡。从手术到第一次肝内复发的过渡概率,没有随后的状态转变,从3%(3个月)增加到17.4%(30个月)和17.2%(60个月)。可能改变这些可能性的因素包括肿瘤大小、卫星病变和微血管侵犯。在线多状态模型计算器可以在https://multistatehcc.shinyapps.io/home/上找到。与标准的单一时间到事件估计相比,多状态模型通过考虑许多术后疾病状态及其之间的转换,为HCC LR后的预后提供了更现实的预测。我们的多状态建模计算器可以提供有意义的数据来指导患者进行术后监测和治疗的管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Dynamic risk profiling of HCC recurrence after curative intent liver resection

Background and Aims

Following liver resection (LR) for HCC, the likelihood of survival is dynamic, in that multiple recurrences and/or metastases are possible, each having variable impacts on outcomes. We sought to evaluate the natural progression, pattern, and timing of various disease states after LR for HCC using multistate modeling and to create a practical calculator to provide prognostic information for patients and clinicians.

Approach and Results

Adult patients undergoing LR for HCC between January 2000 and December 2018 were retrospectively identified at a single center. Multistate analysis modeled post-LR tumor progression by describing transitions between distinct disease states. In this model, the states included surgery, intrahepatic recurrence (first, second, third, fourth, fifth), distant metastasis with or without intrahepatic recurrence, and death. Of the 486 patients included, 169 (34.8%) remained recurrence-free, 205 (42.2%) developed intrahepatic recurrence, 80 (16.5%) developed distant metastasis, and 32 (7%) died. For an average patient having undergone LR, there was a 33.1% chance of remaining disease-free, a 31.0% chance of at least one intrahepatic recurrence, a 16.3% chance of distant metastasis, and a 19.8% chance of death within the first 60 months post-LR. The transition probability from surgery to first intrahepatic recurrence, without a subsequent state transition, increased from 3% (3 months) to 17.4% (30 months) and 17.2% (60 months). Factors that could modify these probabilities included tumor size, satellite lesions, and microvascular invasion. The online multistate model calculator can be found on https://multistatehcc.shinyapps.io/home/.

Conclusions

In contrast to standard single time-to-event estimates, multistate modeling provides more realistic prognostication of outcomes after LR for HCC by taking into account many postoperative disease states and transitions between them. Our multistate modeling calculator can provide meaningful data to guide the management of patients undergoing postoperative surveillance and therapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Hepatology
Hepatology 医学-胃肠肝病学
CiteScore
27.50
自引率
3.70%
发文量
609
审稿时长
1 months
期刊介绍: HEPATOLOGY is recognized as the leading publication in the field of liver disease. It features original, peer-reviewed articles covering various aspects of liver structure, function, and disease. The journal's distinguished Editorial Board carefully selects the best articles each month, focusing on topics including immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases, liver cancer, and drug metabolism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信